The Female Health Co. receives FDA approval for new female contraceptive
CHICAGO The Female Health Company announced Wednesday that its FC2 Female Condom received approval from the Food and Drug Administration.
The FC2 is a woman-initiated barrier method that helps to protect against sexually transmitted infections (STIs), HIV/AIDS and unintended pregnancy.
FHC’s lower-cost second generation female condom will now be available for purchase and distribution in the United States. FDA approval also will enable the United States Agency for International Development to procure FC2 for distribution to global HIV/AIDS programs.
Bayer Diabetes Care helps patients save money, make life easier
TARRYTOWN, N.Y. Bayer Diabetes Care announced Monday the availability of the new Bayer Simple Saver Program, which offers qualified people with diabetes several ways to save on their out-of pocket costs for test strips, making testing more affordable and life with diabetes simpler.
“Bayer is launching the new Simple Saver Program to make glucose monitoring more affordable,” said Michaela Griggs, VP U.S. marketing at Bayer Diabetes Care. “Because the cost of testing supplies can become a burden during an economic climate such as this, we designed our program to offer more options to save on test strips, versus other programs available, to help alleviate this challenge and simplify life for people with diabetes. Now people can continue to test at prescribed levels with less financial worry.”
When a consumer qualifies, Bayer will pay up to $360 per year, depending upon his or her state of residence or health plan.
The Bayer Simple Saver Program can be accessed by consumers via Web site which will be promoted through Bayer advertising, physician offices, online, through Bayer customer service and in pharmacies across the country. Most consumers will be able to save instantly at the pharmacy counter in nearly all locations nationwide.
The program is completely free for consumers and can be used in most states, Bayer reported.
Novartis Consumer Health follows homeopathic trend with Theraflu Cold Pursuit
PARSIPPANY, N.J. To date, there’s only been one notable company to take its venerable homeopathic brand and extend that brand into allopathic therapies. Now there’s a company, Novartis Consumer Health, that’s taking its venerable traditional brand of cough-cold therapies and line extending it with a homeopathic offering — Theraflu Cold Pursuit.
The move signifies the arrival of homeopathy to the mass consumer and at the same time may attract a new shopper to the concept of homeopathy, as the new product will be brand-blocked alongside Novartis’ other Theraflu offerings.
Formulated with two homeopathic cough-cold ingredients, the berry-flavored Theraflu Cold Pursuit begins shipping Aug. 1.